Showing results (141-150 of 288) with videos related to
Sort By:
Pageof 29
Journal of Medical Genetics|March 13, 2019
Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotypeTamar Paperna, Nitzan Sharon-Shwartzman, Alina Kurolap, et al.British Journal of Haematology|January 25, 2003
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapyMartine Szyper-Kravitz, Orit Uziel, Hava Shapiro, et al.Haematologica|May 7, 2011
Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remissionMarc Buyse, Stefan Michiels, Pierre Squifflet, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.Haematologica|April 23, 2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.Cancer|January 19, 2012
A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphomaAvichai Shimoni, Irit Avivi, Jacob M Rowe, et al.Leukemia & Lymphoma|June 2, 2020
A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemiaStephen A Strickland, Xin Victoria Wang, Jan Cerny, et al.Cancer|July 15, 2010
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.Experimental Hematology|February 6, 2014
Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesisRoni Shouval, Liran I Shlush, Shlomit Yehudai-Resheff, et al.Pageof 29